These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 850778)

  • 1. Dissociation of acetylsalicylic acid in blood and joint fluid.
    Soren A
    Scand J Rheumatol; 1977; 6(1):17-22. PubMed ID: 850778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transport of salicylates from blood to joint fluid (author's transl)].
    Soren A
    Wien Klin Wochenschr; 1977 Sep; 89(17):599-602. PubMed ID: 906524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transport time for salicylates from blood to joint fluid-- a test of histopathology of the synovial membrane].
    Soren A
    Z Rheumatol; 1975; 34(5-6):213-20. PubMed ID: 1229742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time for salicylate diffusion from blood to joint fluid. A study of histopathology of the synovial membrane.
    Soren A
    Reumatismo; 1977; 29(1):1-6. PubMed ID: 618099
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of salicylates in blood and joint fluid.
    Soren A
    J Clin Pharmacol; 1975; 15(2-3):173-7. PubMed ID: 1123459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of salicylates from blood to joint fluid.
    Soren A
    Arch Intern Med; 1973 Nov; 132(5):668-72. PubMed ID: 4750223
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers.
    Viganò G; Garagiola U; Gaspari F
    Int J Clin Pharmacol Res; 1991; 11(3):129-35. PubMed ID: 1809699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetics of salicylates from the blood to the articular fluid].
    Soren A
    Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):165-9. PubMed ID: 653293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffusion of aspirin and its metabolites through the synovial membrane].
    Bannwarth B; Netter P; Pourel J; Royer-Morot MJ; Royer RJ; Gaucher A
    Rev Rhum Mal Osteoartic; 1985 May; 52(5):333-6. PubMed ID: 4012212
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma and synovial fluid gentisate in patients receiving salicylate therapy.
    Cleland LG; Lowthian PJ; Imhoff D; Bochner F; Betts WH; O'Callaghan J
    J Rheumatol; 1985 Feb; 12(1):136-9. PubMed ID: 3981499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet.
    Lücker PW; Wetzelsberger N; Schettler T; Rogalla K
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):805-11. PubMed ID: 1297896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentisate, a salicylate metabolite with antioxidant properties.
    Cleland LG; Whitehouse MW; Betts WH
    Drugs Exp Clin Res; 1985; 11(8):463-7. PubMed ID: 3879751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug concentrations in blood, synovial fluid, synovial membrane, periarticular bone, muscle and adipose tissue in patients with rheumatoid polyarthritis receiving a single intramuscular injection of ketoprofen or acetylsalicylic acid (3 hours after the injection)].
    Köhler G; Mohing W; Lutz D; Morand J
    Sem Hop; 1983 Dec; 59(46):3210-3. PubMed ID: 6318343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
    Canada AT; Little AH; Creighton EL
    Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of N-acetylo-beta-hexosamninidase in joint fluid from knee and serum of patients with rheumatoid arthritis and osteoarthritis].
    Popko J; Zalewska A; Sierakowski S; Macias T; Knaś M; Zwierz K; Sredzińska K
    Przegl Lek; 2005; 62(7):650-2. PubMed ID: 16463694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive action and plasma levels of acetylsalicylic acid in the dog.
    O'Dea K; Pütter J; Hoffmeister F
    Arzneimittelforschung; 1975 May; 25(5):801-6. PubMed ID: 1242328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan metabolism in the joint diseases.
    Igari T; Obara K; Ono S; Toba Y
    Acta Vitaminol Enzymol; 1975; 29(1-6):194-7. PubMed ID: 1244092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.